News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
105last 24h
3127last 7d
510● bullish (7d)
311● bearish (7d)
227publishers
Barrons.com2d agoneutral
Why Hims & Hers Health Stock Was in Dire Need of This Eli Lilly AgreementGuruFocus.com4d agoneutral
Novo Nordisk Stocks Rise 5.65% While Higher Guidance Meets Diverging Profit MeasuresYahoo Finance4d agoneutral
Novo Nordisk CEO says CVS breakup has no material impact on the weight-loss drug giantBarrons.com4d agoneutral
Novo Nordisk Stock Shrugs Off Eli Lilly Threat as Weight-Loss Pill Shines in EarningsBarrons.com4d agoneutral
Pfizer CEO Bourla Bets the Viagra Playbook Can Crack the Obesity MarketThe Wall Street Journal4d agoneutral
Novo Nordisk Lifts Guidance as Rollout of Wegovy Weight-Loss Pill ContinuesGuruFocus.com5d agoneutral
Earnings To Watch: Novo Nordisk AS (NVO) Q3 2026 -- GF Value Sees 146% UpsideInvesting.com40d agoneutral
Hengrui Pharma shares rise as Novo Nordisk signs $2.6 billion drug deal